These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20708408)

  • 21. Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerization inhibitors.
    Nakamura H; Kuroda H; Saito H; Suzuki R; Yamori T; Maruyama K; Haga T
    ChemMedChem; 2006 Jul; 1(7):729-40. PubMed ID: 16902927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, biological evaluation of 1,1-diarylethylenes as a novel class of antimitotic agents.
    Hamze A; Giraud A; Messaoudi S; Provot O; Peyrat JF; Bignon J; Liu JM; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M
    ChemMedChem; 2009 Nov; 4(11):1912-24. PubMed ID: 19790205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors.
    Liao SY; Chen JC; Miao TF; Shen Y; Zheng KC
    J Enzyme Inhib Med Chem; 2010 Jun; 25(3):421-9. PubMed ID: 19874191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, cytotoxic effects and tubulin polymerization inhibition of 1,4-disubstituted 1,2,3-triazole analogs of 2-methoxyestradiol.
    Solum EJ; Vik A; Hansen TV
    Steroids; 2014 Sep; 87():46-53. PubMed ID: 24923521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
    Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
    J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replacement of the double bond of antitubulin chalcones with triazoles and tetrazoles: Synthesis and biological evaluation.
    Mesenzani O; Massarotti A; Giustiniano M; Pirali T; Bevilacqua V; Caldarelli A; Canonico P; Sorba G; Novellino E; Genazzani AA; Tron GC
    Bioorg Med Chem Lett; 2011 Jan; 21(2):764-8. PubMed ID: 21167709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin.
    Rappl C; Barbier P; Bourgarel-Rey V; Grégoire C; Gilli R; Carre M; Combes S; Finet JP; Peyrot V
    Biochemistry; 2006 Aug; 45(30):9210-8. PubMed ID: 16866367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triazole linked mono carbonyl curcumin-isatin bifunctional hybrids as novel anti tubulin agents: Design, synthesis, biological evaluation and molecular modeling studies.
    Sharma S; Gupta MK; Saxena AK; Bedi PM
    Bioorg Med Chem; 2015 Nov; 23(22):7165-80. PubMed ID: 26515041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4.
    Ty N; Pontikis R; Chabot GG; Devillers E; Quentin L; Bourg S; Florent JC
    Bioorg Med Chem; 2013 Mar; 21(5):1357-66. PubMed ID: 23369686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antitumor activity of benzils related to combretastatin A-4.
    Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model.
    Schobert R; Biersack B; Dietrich A; Effenberger K; Knauer S; Mueller T
    J Med Chem; 2010 Sep; 53(18):6595-602. PubMed ID: 20731355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
    Barrett I; Carr M; O'Boyle N; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):180-94. PubMed ID: 20222762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isocombretastatins A: 1,1-diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds.
    Alvarez R; Alvarez C; Mollinedo F; Sierra BG; Medarde M; Peláez R
    Bioorg Med Chem; 2009 Sep; 17(17):6422-31. PubMed ID: 19647439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of N(4)-(substituted phenyl)-N(4)-alkyl/desalkyl-9H-pyrimido[4,5-b]indole-2,4-diamines and identification of new microtubule disrupting compounds that are effective against multidrug resistant cells.
    Gangjee A; Zaware N; Devambatla RK; Raghavan S; Westbrook CD; Dybdal-Hargreaves NF; Hamel E; Mooberry SL
    Bioorg Med Chem; 2013 Feb; 21(4):891-902. PubMed ID: 23332369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
    Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
    J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and cytotoxic evaluation of N-(4-methoxy-1H-benzo[d]imidazol-7-yl)-arylsulfonamide and N-aryl-(4-methoxy-1H-benzo[d]imidazol)-7-sulfonamide analogs of combretastatin A-4.
    Zhou J; Zhang Y; Cui YW; Li ZM; Song HR; Dong JH; Chen XG; Xu BL
    J Asian Nat Prod Res; 2011 Apr; 13(4):330-40. PubMed ID: 21462036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.
    Liou JP; Chang JY; Chang CW; Chang CY; Mahindroo N; Kuo FM; Hsieh HP
    J Med Chem; 2004 May; 47(11):2897-905. PubMed ID: 15139768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of small molecule inhibitors that interact with γ-tubulin.
    Friesen DE; Barakat KH; Semenchenko V; Perez-Pineiro R; Fenske BW; Mane J; Wishart DS; Tuszynski JA
    Chem Biol Drug Des; 2012 May; 79(5):639-52. PubMed ID: 22268380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.
    Liu T; Dong X; Xue N; Wu R; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(17):6279-85. PubMed ID: 19665898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents.
    Qian Y; Ma GY; Yang Y; Cheng K; Zheng QZ; Mao WJ; Shi L; Zhao J; Zhu HL
    Bioorg Med Chem; 2010 Jun; 18(12):4310-6. PubMed ID: 20493717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.